Gleevec (imatinib mesylate)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Gleevec (imatinib mesylate), covering 2011-08-08 to 2014-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC) [Phase 1]